The North America DNA vaccine market is projected to rise with a CAGR of 42.35% for the forecast period of 2018-2026, generating the highest revenue share of $XX million by the end of this period.The report covers a detailed market analysis of countries like the United States and Canada for this region. Factors like the application of DNA vaccines in curbing the growing prevalence of diseases and the resultant rise in investments for third generation vaccines are particularly responsible for the expansion of the market. The region is also witnessing a growing adoption of these vaccines for veterinary purposes.
NORTH AMERICA DNA VACCINE MARKET FORECAST 2018-2026
North America DNA Vaccine Market by Type (Animal DNA Vaccine, Human DNA Vaccine) by Application (Human Disease, Veterinary Disease) by Technology (Plasmid DNA Vaccines, Plasmid DNA Delivery) by Geography
The North America DNA vaccine market is projected to rise with a CAGR of 42.35% for the forecast period of 2018-2026, generating the highest revenue share of $XX million by the end of this period.
To learn more about this report, request a free sample copy
The report covers a detailed market analysis of countries like the United States and Canada for this region. Factors like the application of DNA vaccines in curbing the growing prevalence of diseases and the resultant rise in investments for third generation vaccines are particularly responsible for the expansion of the market. The region is also witnessing a growing adoption of these vaccines for veterinary purposes. On the basis of technology, the market is chiefly segmented into plasmid DNA vaccines and plasmid DNA delivery. Since these vaccines are non-recreating and cause no or little harm, they are increasingly being preferred over traditional vaccines.
Companies like Madison Vaccines Incorporated (MVI), Merck & Co, Glaxosmithkline Inc, Xenetic Biosciences Inc, Novartis Ag, Astellas Pharma Inc, Vical Incorporated and Inovio Pharmaceuticals Inc are some of the important players in DNA vaccine market.
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- MARKET DETERMINANTS
- DRIVERS
- DNA VACCINES SHOWS GREAT PROMISE IN CHECKING THE RISING PREVALENCE OF DISEASE
- THIRD GENERATION VACCINATION IS SEEING A SURGE IN INVESTMENT
- INCREASING ADOPTION OF DNA VACCINES FOR ANIMAL HEALTHCARE
- RESTRAINTS
- LENGTHY REGULATORY PROCESS
- POOR PATENT PROTECTION IN SOME COUNTRIES
- OPPORTUNITIES
- TRANSFORMING HEALTHCARE LANDSCAPE
- NEW DEVELOPMENTS IN BIOTECHNOLOGIES AND NANOTECHNOLOGIES
- STABLE VACCINES MAKE IT ATTRACTIVE TO STORE AND TRANSPORT
- CHALLENGES
- VACCINES FOR HUMAN USAGE STILL UNDER CLINIC TRAIL PHASE
- DRIVERS
- MARKET SEGMENTATION
- MARKET BY TYPE 2018-2026
- ANIMAL DNA VACCINE
- HUMAN DNA VACCINE
- MARKET BY APPLICATION 2018-2026
- HUMAN DISEASE
- VETERINARY DISEASE
- MARKET BY TECHNOLOGY 2018-2026
- PLASMID DNA VACCINES
- PLASMID DNA DELIVERY
- MARKET BY TYPE 2018-2026
- KEY ANALYTICS
- PORTER’S FIVE FORCE MODEL
- THREAT OF NEW ENTRANTS
- THREATS OF SUBSTITUTE PRODUCT
- BARGAINING POWER OF BUYER
- BARGAINING POWER OF SUPPLIER
- INTENSITY OF COMPETITIVE RIVALRY
- KEY BUYING CRITERIA
- EFFICACY
- COST-EFFECTIVENESS
- STABILITY
- KEY MARKET PLAYERS
- VICAL INCORPORATED
- SANOFI
- MERCK AND CORP
- GSK
- OPPORTUNITY MATRIX
- VALUE CHAIN ANALYSIS
- R&D
- MANUFACTURING
- RAW MATERIALS
- MARKETING, DISTRIBUTION & END USER
- LEGAL, POLICY AND REGULATORY FRAMEWORK
- PORTER’S FIVE FORCE MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- STRATEGIC INITIATIVES
- ACQUISITION
- PARTNERSHIP
- COLLABORATION
- INNOVATION
- DISINVESTMENT
- EXPANSION
- STRATEGIC INITIATIVES
- COMPANY PROFILE
- MARKET SHARE
- ASTELLAS PHARMA INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- DENDREON CORPORATION (ACQUIRED BY SANPOWER GROUP)
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- ELI LILLY AND COMPANY
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- EUROGENTEC S.A
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- GLAXOSMITHKLINE INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- INOVIO PHARMACEUTICALS, INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- MADISON VACCINES INCORPORATED (MVI)
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- MERIAL LIMITED (ACQUIRED BY BOEHRINGER INGELHEIM)
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- MERCK & CO.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- NOVARTIS AG
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- SANOFI
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- VGXI
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVES
- VICAL INCORPORATED
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATIVE
- XENETIC BIOSCIENCES INC.
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATES
- ZOETIS INC
- OVERVIEW
- PRODUCT PORTFOLIO
- SCOT ANALYSIS
- STRATEGIC INITIATES
LIST OF TABLES
TABLE 1 NORTH AMERICA DNA VACCINE MARKET 2018-2026 ($ MILLION)
TABLE 2 INTERVENTIONS AND PHASE OF CERTAIN DISEASE/CONDITIONS
TABLE 3 APPROACHES BEING TESTED TO ENHANCE THE LOW IMMUNOGENICITY
TABLE 4 CLINICAL TRIALS OF HUMANS INVOLVING DNA VACCINES
TABLE 5 TEMPERATURE REQUIREMENTS IN PRESERVATION FOR VARIOUS VACCINES
TABLE 6 NORTH AMERICA DNA VACCINE MARKET BY TYPE 2018-2026 ($ MILLION)
TABLE 7 NORTH AMERICA DNA VACCINE MARKET IN ANIMAL DNA VACCINE 2018-2026($MILLION)
TABLE 8 NORTH AMERICA DNA VACCINE MARKET IN HUMAN DNA VACCINE 2018-2026
TABLE 9 NORTH AMERICA DNA VACCINE MARKET BY APPLICATION 2018-2026 ($ MILLION)
TABLE 10 NORTH AMERICA DNA VACCINE MARKET IN HUMAN DISEASES APPLICATION 2018-2026 ($MILLION)
TABLE 11 NORTH AMERICA DNA VACCINE MARKET IN VETERINARY APPLICATION 2018-2026
TABLE 12 NORTH AMERICA DNA VACCINE MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
TABLE 13 NORTH AMERICA DNA VACCINE MARKET IN PLASMID DNA VACCINES TECHNOLOGY 2018-2026
TABLE 14 NORTH AMERICA DNA VACCINE MARKET IN PLASMID DNA DELIVERY TECHNOLOGY 2018-2026
TABLE 15 REGULATIONS TO BE FOLLOWED BEFORE COMMERCIALIZATION
LIST OF FIGURES
FIGURE 1 NORTH AMERICA DNA VACCINE MARKET 2018-2026 ($ MILLION)
FIGURE 2 NORTH AMERICA DNA VACCINE MARKET 2018-2026 ($ MILLION)
FIGURE 3 NORTH AMERICA DNA VACCINE MARKET IN VETERINARY DISEASES 2018-2026 ($ MILLION)
FIGURE 4 SHARE OF TRIALS BY VACCINE TARGET IN 2016
FIGURE 5 SEGMENT OF CLINICAL TRIALS OF DNA VACCINE BY CANCER MARKS IN 2016
FIGURE 6 CLINICAL TRIALS OF GENE THERAPY
FIGURE 7 NORTH AMERICA DNA VACCINE MARKET SHARE BY TYPE 2017 & 2026 (%)
FIGURE 8 NORTH AMERICA DNA VACCINES MARKET IN ANIMAL DNA VACCINES 2018-2026 ($ MILLION)
FIGURE 9 NORTH AMERICA DNA VACCINE MARKET IN HUMAN DNA VACCINES 2018-2026($ MILLION)
FIGURE 10 NORTH AMERICA DNA VACCINE MARKET SHARE BY APPLICATION 2017 & 2026 (%)
FIGURE 11 NORTH AMERICA DNA VACCINES MARKET IN HUMAN DISEASES 2018-2026 ($ MILLION)
FIGURE 12 NORTH AMERICA DNA VACCINES MARKET IN VETERINARY APPLICATION 2018-2026 ($ MILLION)
FIGURE 13 NORTH AMERICA DNA VACCINES MARKET IN PLASMID DNA VACCINES TECHNOLOGY 2018-2026 ($ MILLION)
FIGURE 14 NORTH AMERICA DNA VACCINES MARKET IN PLASMID DNA DELIVERY TECHNOLOGY 2018-2026 ($ MILLION)
FIGURE 15 VALUE CHAIN ANALYSES FOR DNA VACCINE INDUSTRY
FIGURE 16 UNITED STATES DNA VACCINE MARKET 2018-2026 ($ MILLION)
FIGURE 17 CANADA DNA VACCINE MARKET 2018-2026 ($ MILLION)
FIGURE 18 MARKET SHARES OF TOP FIVE COMPANIES FOR DNA VACCINES MARKET IN 2017
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET SEGMENTATION
- MARKET BY TYPE 2018-2026
- ANIMAL DNA VACCINE
- HUMAN DNA VACCINE
- MARKET BY APPLICATION 2018-2026
- HUMAN DISEASE
- VETERINARY DISEASE
- MARKET BY TECHNOLOGY 2018-2026
- PLASMID DNA VACCINES
- PLASMID DNA DELIVERY
- MARKET BY TYPE 2018-2026
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.